[Advances in the treatment of morbus Hodgkin (author's transl)].
D000970:Antineoplastic Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D011379:Prognosis; D011879:Radiotherapy Dosage
D000970:Antineoplastic Agents
Zur Therapie des Morbus Hodgkin (M.H.).